Irene B.
- Country
- Spain
- Department
- Oncology
Research Overview
- Phase I Dose Escalation and Cohort Expansion Study of LB-208, a HTR1B Antagonist, in Adults with Relapsed or Refractory Solid Tumors and Lymphoma
- Phase I/II Study of TG4050 in Patients with Stage III/IV HPV-Negative Squamous-Cell Carcinoma of the Head and Neck Post-Surgery and Adjuvant Therapy
- Evaluation of REGN6569 and Cemiplimab in Adults with Advanced Squamous Cell Carcinoma of the Head and Neck
Data & Insights
Has run more than one trial at 175 of 312 partner sites.
Specializations
Oncology Focus
This investigator specializes in treating advanced solid tumors with particular expertise in developing innovative therapeutic approaches using targeted therapies like PARP1 selective inhibitors.
- Novel therapeutic compounds
- Advanced solid tumor management
- First-in-human studies
The investigator's work involves evaluating new treatment options for patients with advanced cancers.
Head and Neck Cancer
The investigator has significant expertise in treating head and neck squamous cell carcinoma, particularly focusing on recurrent and metastatic disease.
- First-line treatment strategies
- Immunotherapy combinations
- PD-L1 positive tumors
Their research encompasses innovative combination approaches using immunotherapy and targeted agents.
Immunotherapy Research
The investigator explores novel immunotherapy combinations, including work with checkpoint inhibitors and their integration with conventional treatment approaches.
- Combination therapy development
- Chemotherapy integration
- Treatment resistance
Their work focuses on optimizing therapeutic combinations for enhanced treatment outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.